In our December issue of Pharmaceutical Executive
FEATURES
Cover Story
Science's Storyteller: NOVA Producer Paula Apsell
Casey McDonald
Pharm Exec sits down with veteran journalist Paula Apsell, the driving force behind the long-running PBS science series NOVA, for some straightforward advice to the biopharma industry. |
From the Editor
Science: The Communal Language
William Looney
Despite industry's success in translating discovery research into products with proven clinical value, it continues to struggle in positioning medical research to the public as a distinctive force for good. |
Emerging Markets
Investing in Africa: How to Do It Right
William Looney
Pharm Exec talks with Les Funtleyder, portfolio manager for New York-based E Squared Capital and consulting partner to Blue Cloud Investments, a private equity investor focused on midmarket opportunities in the sub-Saharan region of Africa. |
Corporate Strategy
Executive Pay and Innovation
Carl Sjostrom, Ian Wilcox
Carl Sjostrom and Ian Wilcox on the how need for biopharma innovation extends to questions around executive compensation. |
Manufacturing
The Steps to 'Excellence'
John Furey, Matt Humphreys, Alex Sabad
How a Manufacturing Excellence program can deliver competitive advantage to a fast-changing global product mix—at lower cost, and with an unexpected workforce dividend to boot. |
 |
ALSO IN THIS ISSUE
Will NICE Go Commerial?
Leela Barham
Leela looks at the 18 recommendations of England's Accelerated Access Review, which proposes how to speed up adoption of the best innovation in the NHS …Read more
What Trump Means for Pharma Regulation
Jill Wechsler
Republican control of Washington promises overhaul of healthcare and medical product regulation …Read more
Cleveland Clinic's Top Innovations for 2017
Casey McDonald
Cleveland Clinic looks at the big medical innovations in store for 2017 ……Read more
|
|
| |
| WEBCASTS |
| Commercializing Drugs with Companion Diagnostics |
| How the Life Sciences Cloud Coalition Is Driving Greater Innovation and Collaboration for Sponsors |
Supporting internal and external decision-making through effective MSL activities
|
Achieving Success in the Biosimilar Market
|
Why Patient Support Programs Need a Personal Approach
|
